Skip to main content
Clinical Trials/NCT00629434
NCT00629434
Terminated
Not Applicable

A Comparison of Diabetes Group Education as Administered Through Telemedicine Versus as Administered in Person

State University of New York - Upstate Medical University1 site in 1 country68 target enrollmentJune 2001

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetes Mellitus
Sponsor
State University of New York - Upstate Medical University
Enrollment
68
Locations
1
Primary Endpoint
A1c
Status
Terminated
Last Updated
4 years ago

Overview

Brief Summary

This study compares group diabetes education in-person versus via telemedicine

Detailed Description

Diabetes education is important in the treatment of the person with diabetes. A diabetes self-management education program not only educates the patient and his/her family to the basics of diabetes care but also integrates diabetes care into daily life while providing coping skills to adjust to this chronic illness. Unfortunately, comprehensive diabetes care is not available to all persons with diabetes. One obstacle to the provision of comprehensive diabetes care is the unavailability of a diabetes treatment center. many people with diabetes live too far or do not have the transportation to be able to attend education programs that met national standards. We have shown that telemedicine is an effective means to provide comprehensive 1:1 individualized diabetes education to persons with diabetes. We now propose to test the hypothesis that diabetes groups education classes can be provided effectively through telemedicine technology to individuals living in rural areas. Patients with diabetes will received diabetes education via teleconferencing from our Joslin Diabetes center. The participants will be assessed before and after diabetes education via telemedicine using measures of glycemia (A1c) and assessments of patient satisfaction, emotional well being, and behavioral change and compared to results from participants attending our diabetes education classes in-person.

Registry
clinicaltrials.gov
Start Date
June 2001
End Date
August 2008
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
State University of New York - Upstate Medical University

Eligibility Criteria

Inclusion Criteria

  • Type 1 or type 2 diabetes mellitus
  • age \> 18 years

Exclusion Criteria

  • Profound vision loss
  • Severe hearing impairment

Outcomes

Primary Outcomes

A1c

Time Frame: baseline, 3 mo post intervention, 6 mo post intervention

Secondary Outcomes

  • PAID scale(baseline, 3 and 6 months post intervention)
  • Diabetes Treatment Satisfaction Questionnaire(Baseline, 3 and 6 months post intervention)

Study Sites (1)

Loading locations...

Similar Trials